You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 20, November 13, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (44)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The Andro Project

Physiological and Hormonal Influences of Androstenedione Supplementation in Men 35 to 65 Years Old Participating in a High-Intensity Resistance Training Program

C. E. Broeder, PhD; J. Quindry, MS; K. Brittingham, MA; L. Panton, PhD; J. Thomson, MA; S. Appakondu, MD; K. Breuel, PhD; R. Byrd, MD; J. Douglas, MD; C. Earnest, PhD; C. Mitchell, PhD; M. Olson, MS; T. Roy, MD; C. Yarlagadda, MD

Arch Intern Med. 2000;160:3093-3104.

Background  Since the passage of The Dietary Supplement Health and Education Act in 1994, there has been a flood of new "dietary" supplements promoting anti-aging benefits such as the enhancement of growth hormone or testosterone levels. Androstenediol and androstenedione are such products. This study's purpose was to elucidate the physiological and hormonal effects of 200 mg/d of oral androstenediol and androstenedione supplementation in men aged 35 to 65 years while participating in a 12-week high-intensity resistance training program.

Methods  Fifty men not consuming any androgenic-enhancing substances and with normal total testosterone levels, prostate-specific antigen, hemoglobin, and hematocrit, and with no sign of cardiovascular or metabolic diseases participated. Subjects were randomly assigned to a placebo, androstenediol (diol), or androstenedione (dione) group using a double-blind study design. Main outcomes included serum sex hormone profile, body composition assessment, muscular strength, and blood lipid profiles.

Results  During the 12 weeks of androstenedione or androstenediol use, a significant increase in the aromatization by-products estrone and estradiol was observed in both groups (P = .03). In the dione group, total testosterone levels significantly increased 16% after 1 month of use, but by the end of 12 weeks, they returned to pretreatment levels. This return to baseline levels resulted from increases in aromatization and down-regulation in endogenous testosterone synthesis based on the fact that luteinizing hormone was attenuated 18% to 33% during the treatment period. Neither androstenediol nor androstenedione enhanced the adaptations to resistance training compared with placebo for body composition or muscular strength. However, both androstenediol and androstenedione supplementation adversely affected high-density lipoprotein cholesterol (HDL-C) levels, coronary heart disease risk (representing a 6.5% increase), and each group's respective (low-density lipoprotein cholesterol [LDL-C]/HDL-C)/(apolipoprotein A/apolipoprotein B) lipid ratio (diol: +5.2%; dione: +10.5%; P = .05). In contrast, the placebo group's HDL-C levels increased 5.1%, with a 12.3% decline in the (LDL-C/HDL-C)/(apolipoprotein A/apolipoprotein B) lipid ratio. These negative and positive lipid effects occurred despite no significant alterations in body composition or dietary intakes in the supplemental groups or placebo group, respectively.

Conclusions  Testosterone precursors do not enhance adaptations to resistance training when consumed in dosages recommended by manufacturers. Testosterone precursor supplementation does result in significant increases in estrogen-related compounds, dehydroepiandrosterone sulfate concentrations, down-regulation in testosterone synthesis, and unfavorable alterations in blood lipid and coronary heart disease risk profiles of men aged 35 to 65 years.


From the Departments of Physical Education, Exercise, and Sports Science (Drs Broeder and Panton, Mr Quindry, and Mss Brittingham and Thomson) and Human Development and Learning (Dr Mitchell), East Tennessee State University; the Departments of Physiology (Drs Broeder and Mr Quindry), Internal Medicine (Drs Appakondu, Byrd, Douglas, Roy, and Yarlagadda), and Obstetrics and Gynecology (Dr Breuel), James H. Quillen–College of Medicine, Johnson City, Tenn; and Metabolic Response Modifiers, Huntington Beach, Calif (Dr Earnest and Mr Olson).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ulnar Deep Venous Thrombosis in a Professional Baseball Pitcher: A Case Report
Hurbanek et al.
Am J Sports Med 2007;35:2131-2134.
FULL TEXT  

Popular Ergogenic Drugs and Supplements in Young Athletes
Calfee and Fadale
Pediatrics 2006;117:e577-e589.
ABSTRACT | FULL TEXT  

Orthopaedic Care of the Aging Athlete
Chen et al.
J Am Acad Orthop Surg 2005;13:407-416.
ABSTRACT | FULL TEXT  

{Delta}-4-Androstene-3,17-Dione Binds Androgen Receptor, Promotes Myogenesis in Vitro, and Increases Serum Testosterone Levels, Fat-Free Mass, and Muscle Strength in Hypogonadal Men
Jasuja et al.
J. Clin. Endocrinol. Metab. 2005;90:855-863.
ABSTRACT | FULL TEXT  

Effects of Oral Administration of Androstenedione on Plasma Androgens in Young Women Using Hormonal Contraception
Bassindale et al.
J. Clin. Endocrinol. Metab. 2004;89:6030-6038.
ABSTRACT | FULL TEXT  

Urinary Excretion of Steroid Metabolites after Chronic Androstenedione Ingestion
Brown et al.
J. Clin. Endocrinol. Metab. 2004;89:6235-6238.
ABSTRACT | FULL TEXT  

Ergogenic Aids: A Review of Basic Science, Performance, Side Effects, and Status in Sports
Tokish et al.
Am J Sports Med 2004;32:1543-1553.
ABSTRACT | FULL TEXT  

Asynchronous Bilateral Achilles Tendon Ruptures and Androstenediol Use
Battista et al.
Am J Sports Med 2003;31:1007-1009.
FULL TEXT  

Use and Effectiveness of Performance-Enhancing Substances
Boyce
Journal of Pharmacy Practice 2003;16:22-36.
ABSTRACT  

Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis
Nissen and Sharp
J. Appl. Physiol. 2003;94:651-659.
ABSTRACT | FULL TEXT  

Effects of Oral Androstenedione Administration on Serum Testosterone and Estradiol Levels in Postmenopausal Women
Leder et al.
J. Clin. Endocrinol. Metab. 2002;87:5449-5454.
ABSTRACT | FULL TEXT  

Endocrine and Lipid Responses to Chronic Androstenediol-Herbal Supplementation in 30 to 58 Year Old Men
Brown et al.
J. Am. Coll. Nutr. 2002;20:520-528.
ABSTRACT | FULL TEXT  

Acute hormonal response to sublingual androstenediol intake in young men
Brown et al.
J. Appl. Physiol. 2002;92:142-146.
ABSTRACT | FULL TEXT  

Anabolic Steroids
Kuhn
Recent Prog Horm Res 2002;57:411-434.
ABSTRACT | FULL TEXT  

Androstenedione Supplements Not Helpful, Maybe Harmful
JWatch General 2000;2000:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.